Filtered By:
Source: Annals of Oncology
Drug: Alimta
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools
ConclusionsThese findings identify for the first time PCFT as a novel mesothelioma prognostic biomarker, prompting prospective trials for its validation. Moreover, preclinical data suggest that targetingPCFT-promoter methylation might eradicate pemetrexed-resistant cells characterized by low-PCFT expression.
Source: Annals of Oncology - September 7, 2017 Category: Cancer & Oncology Source Type: research
